Inhibition of BMP signaling pathway induced senescence and calcification in anaplastic meningioma

Kiyotaka Yokogami1, Takashi Watanabe2, Shinji Yamashita2

  • 1Department of Neurosurgery, Faculty of Medicine, University of Miyazaki, Miyazaki, 889-1692, Japan. akatoyik@med.miyazaki-u.ac.jp.

PubMed
Abstract

Insights

Targeting the GREM2-BMPR1A pathway in meningiomas offers a new therapeutic strategy. This approach modulates tryptophan metabolism, reduces energy production, and induces senescence in malignant brain tumors.

Area of Science:

  • Neuro-oncology
  • Molecular Biology
  • Cancer Metabolism

Background:

  • Meningiomas are common brain tumors, often benign, but malignant subtypes recur with poor prognosis.
  • Current treatments for recurrent meningiomas are limited, highlighting the need for novel therapeutic targets.
  • Meningioma metabolism remains poorly understood, hindering the development of effective treatments.

Purpose of the Study:

  • To identify a novel therapeutic target for recurrent and malignant meningiomas.
  • To investigate the role of bone morphogenetic protein (BMP) signaling and Gremlin2 (GREM2) in meningioma progression.
  • To elucidate the metabolic alterations in malignant meningiomas.

Main Methods:

  • Examined the effects of a BMP signal inhibitor (K02288) and GREM2 on meningioma growth and senescence.
  • Assessed proliferation by inhibiting BMP signaling and analyzed GREM2 overexpression.
  • Correlated GREM2 mRNA expression with proliferation markers in clinical samples and analyzed RNA-seq data.
  • Investigated metabolic and senescence marker changes following BMP signal suppression.

Main Results:

  • Inhibiting BMP receptor (BMPR1A) and overexpressing GREM2 shifted tryptophan metabolism towards serotonin, reducing NAD+/NADH and ATP production.
  • Decreased expression of genes involved in oxidative phosphorylation was observed in malignant meningiomas.
  • Malignant meningiomas exhibited cellular senescence, reduced proliferation, and psammoma body formation.
  • Analysis of clinical and public RNA-seq data confirmed that increased GREM2 expression correlates with reduced oxidative phosphorylation gene expression.

Conclusions:

  • The GREM2-BMPR1A-tryptophan metabolic pathway represents a potential therapeutic target for meningiomas.
  • Modulating this pathway may offer a new strategy for treating aggressive meningioma subtypes.
  • Understanding meningioma metabolism is crucial for developing targeted therapies.

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.5K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
8.9K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K